Mevlut Baskol

Mevlut Baskol

Auto-generated profile, based on publicly available information

Mevlut Baskol

Department of Gastroenterology, Faculty of Medicine, Erciyes University, Kayseri, Turkey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
MBMevlut Baskol
Mevlut Baskol
GBGulden Baskol
Gulden Baskol
DKDerya Koçer
Derya Koçer
OOOmer Ozbakir
Omer Ozbakir
MYMehmet Yucesoy
Mehmet Yucesoy
Background/Goals The etiology and pathogenesis of chronic inflammatory bowel diseases are still poorly understood. Oxidative stress takes place in the pathogenesis of ulcerative colitis (UC) and advanced oxidation protein products (AOPP) are accepted as a novel marker of oxidative stress. There are no data concerning whether AOPP may be used as a simple serum marker to assess the disease activity, predict severity of the disease course in UC. Study In this study, we determine the importance of neutrophil activation and the role of oxidative stress in the pathogenesis of UC, by quantification of AOPP and total thiol levels as markers of oxidative protein damage, malondialdehyde levels as a marker of lipid peroxidation, and myeloperoxidase activity as a marker of neutrophil activation in patients with UC. Results Serum levels of AOPP, thiol, myeloperoxidase activity, and malondialdehyde were found as increased in UC group compared with controls (P=0.004, 0.047, 0.001, and 0.001 respectively). Conclusions Our finding of increased levels of plasma AOPP levels supports the presence of oxidative stress and protein oxidation in UC and this marker may be used as a simple serum marker to assess disease activity, predict the severity of disease course, and perhaps response to therapy.

22 April 2015 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
MBMevlut Baskol
Mevlut Baskol
KSKiymet Dolbun Seckin
Kiymet Dolbun Seckin
GBGulden Baskol
Gulden Baskol
Background/Aims: In this study we aim to evaluate the relationship of advanced oxidation protein products (AOPP), total thiol, total antioxidant status (TAS), total oxidant status (TOS) levels and oxidative stress index (OSI) in patients with nonalcoholic steatohepatitis (NASH). Materials and Methods: A total of 28 patients with NASH and 19 age-and-gender-matched healthy subjects were enrolled in the study as control group. Plasma AOPP and thiol levels were determined by spectrophotometric methods. Plasma TAS and TOS levels were measured using commercially available kits and OSI was calculated. Results: Plasma AOPP (256.7 vs. 125.8 μmol/L) and TOS levels (8.9 vs. 5.9 μmol H2O2 equiv/L) were higher in patients with NASH than the controls (p<0.019 and p<0.041 respectively). Plasma total thiol levels (235.0 vs. 291.6 μmol/L) were lower in patients with NASH than the controls (p0.900). OSI values (8.0 vs. 5.5) were higher in patients with NASH than the controls (p<0.039). Conclusion: Our findings indicate that oxidative stress increases in patients with NASH as shown by increases in TOS level. We think effective antioxidant therapy to inhibit protein oxidation and also to increase of TAS and total thiol levels may be a therapeutic option in patients with NASH who have under increased oxidative stress.

1 July 2004 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
MBMevlut Baskol
Mevlut Baskol
OOOmer Ozbakir
Omer Ozbakir
RCRamazan Coşkun
Ramazan Coşkun
GBGulden Baskol
Gulden Baskol
RSRecep Saraymen
Recep Saraymen
MYMehmet Yucesoy
Mehmet Yucesoy
To determine the prevalence of muscle cramps in patients with liver cirrhosis and to identify factors associated with their development, especially serum zinc. One hundred cirrhotic patients and 85 healthy subjects were enrolled into the study. True muscle cramp was defined as at least 1 painful leg cramp either occurring at rest or strong enough to waken a patient from sleep, occurring at least once a week persisting for a period of greater than 1 year. Creatinine, calcium, magnesium, sodium, potassium, zinc, glucose, alanine aminotransferase, total bilirubin, and albumin levels were detected in sera. Prothrombine time was measured in cirrhotic patients. Presence or absence of ascite was determined by sonography. True muscle cramps were significantly more common in patients with cirrhosis when compared with the control group (59% vs. 7.1%, respectively, P < 0.001). Cramp (+) cirrhotic patients had older age (49.54 +/- 10.09 vs. 55.54 +/- 7.90, respectively; p: 0.001) and higher Child-Pugh scores (7.56 +/- 2.32 vs. 9.02 +/- 2.55, respectively; p: 0.004) when compared with cramp (-) patients. None of the serum related factors such as creatinine, calcium, magnesium, sodium, potassium, zinc, glucose, alanine aminotransferase, total bilirubin, and albumin levels had any statistically significant contribution to the etiology. Muscle cramps are frequent complication of cirrhosis. Neither biochemical characteristics including decreased serum zinc levels nor the use of diuretics explained the greater prevalence of cramps in patients with cirrhosis. We conclude that the detrimental effect of cirrhosis on muscle fibers may be the major factor.

1 January 2012 in The Journal of Alternative and Complementary Medicine
Verified
Journal Article
Closed access
AKAhmet Karaman
Ahmet Karaman
MBMevlut Baskol
Mevlut Baskol
SGSebnem Gursoy
Sebnem Gursoy
ETEdip Torun
Edip Torun
AYAlper Yurci
Alper Yurci
MYMehmet Yucesoy
Mehmet Yucesoy
Aim: This was a prospective study investigating the efficacy of Ankaferd Blood Stopper® (ABS), an herbal preparation, in patients with upper gastrointestinal (UGI) bleeding. Materials and methods: A total of 30 patients (22 male, 8 female) who had UGI bleeding (with differing causes) were included in the study. ABS was used to stop the bleeding. Results: Primary hemostasis was achieved in 26 of the 30 cases. Conclusions: ABS is an effective and safe agent to use in patients with UGI bleeding.

8 August 2026 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
BTBusra Turkmen
Busra Turkmen
MYMerve Özel Yetkin
Merve Özel Yetkin
EKEzgi Yenişekerci Kulak
Ezgi Yenişekerci Kulak
GBGulden Baskol
Gulden Baskol
MBMevlut Baskol
Mevlut Baskol

4 September 2024 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
ZCZehra Nur Caliskan
Zehra Nur Caliskan
MYMerve Ozel Yetkin
Merve Ozel Yetkin
MBMevlut Baskol
Mevlut Baskol
GBGulden Baskol
Gulden Baskol
Objectives: Cholangiocarcinoma (CCA) is a highly heterogeneous biliary malignant tumor. Studies have demonstrated that JAK/STAT signaling is activated in many types of cancer. In addition, JAK/STAT is activated downstream of AXL, and the AXL receptor is activated by its ligand, GAS6. In this study, we investigated the anticarcinogenic effect of silibinin and its relationship with the GAS6/AXL ve JAK/STAT pathway in the human EGI-1 cell line. Methods: Cell viability, apoptosis, and cell cycle were measured by Muse Cell Analyzer. All the protein levels were determined by the ELISA method. Results: We observed that silibinin significantly reduced cell proliferation and colony formation (p<0.05, p<0.001, respectively). Silibinin also significantly induced total apoptosis and the G0/G1 phase of the cell cycle (p<0.01). We observed that silibinin significantly decreased JAK2 levels while increased STAT1 levels compared to the controls respectively (p<0.001; p0.05). Conclusions: Silibinin reduces colony formation, inducing apoptosis and arresting cancer cells in the G0/G1 phase, which is an indicator of its anticancer activity. In addition, silibinin decreased the levels of JAK2 and sAXL, which contributes to the development of cancer, and increased the levels of STAT1, suggesting silibinin’s antiproliferative effects.